Cargando…

Weight Change and Incident Distal Colorectal Adenoma Risk in the PLCO Cancer Screening Trial

BACKGROUND: Although obesity is a known risk factor, the impact of weight change on colorectal adenoma risk is less clear and could have important implications in disease prevention. We prospectively evaluated weight change in adulthood and incident colorectal adenoma. METHODS: We assessed weight ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Shisi, Berndt, Sonja I, Kunzmann, Andrew T, Kitahara, Cari M, Huang, Wen-Yi, Barry, Kathryn Hughes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804223/ https://www.ncbi.nlm.nih.gov/pubmed/35112050 http://dx.doi.org/10.1093/jncics/pkab098

Ejemplares similares

Body mass index and mortality among blacks and whites in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
por: Xiao, Qian, et al.
Publicado: (2013)

Relationship between prediagnostic body mass index trajectory and colorectal adenomas: an analysis of the PLCO cancer screening trial
por: Luo, Linna, et al.
Publicado: (2020)

Prospective study of the relationship between coffee and tea with colorectal cancer risk: The PLCO Cancer Screening Trial
por: Dominianni, C, et al.
Publicado: (2013)

Meat consumption and the risk of incident distal colon and rectal adenoma
por: Ferrucci, L M, et al.
Publicado: (2012)

Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort
por: Zheng, Rui, et al.
Publicado: (2018)

Detection method has independent prognostic significance in the PLCO lung screening trial
por: Long, James P., et al.
Publicado: (2023)

Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies
por: Petrick, Jessica L, et al.
Publicado: (2017)

The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort
por: Kawakita, Daisuke, et al.
Publicado: (2018)

White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
por: Sturgeon, Susan R., et al.
Publicado: (2017)

Seropositivity for Helicobacter pylori and hepatobiliary cancers in the PLCO study
por: Makkar, Rishi, et al.
Publicado: (2020)

Dairy Product Consumption and Bladder Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cohort
por: Xu, Xin
Publicado: (2020)

Understanding the ever-changing incidence of thyroid cancer
por: Kitahara, Cari M., et al.
Publicado: (2020)

Randomization to Screening for Prostate, Lung, Colorectal and Ovarian Cancers and Thyroid Cancer Incidence in Two Large Cancer Screening Trials
por: O'Grady, Thomas J., et al.
Publicado: (2014)

Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort
por: Hashibe, Mia, et al.
Publicado: (2015)

Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas
por: Schernhammer, E S, et al.
Publicado: (2003)

Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort
por: Lacey, James V, et al.
Publicado: (2009)

Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
por: Smith, Amelia, et al.
Publicado: (2018)

Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
por: Tammemägi, Martin C., et al.
Publicado: (2014)

GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO Atlas
por: Machiela, Mitchell J., et al.
Publicado: (2023)

Correction: Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
Publicado: (2015)

Time to First Morning Cigarette and Risk of Chronic Obstructive Pulmonary Disease: Smokers in the PLCO Cancer Screening Trial
por: Guertin, Kristin A., et al.
Publicado: (2015)

US gynecologists’ estimates and beliefs regarding ovarian cancer screening’s effectiveness 5 years after release of the PLCO evidence
por: Wegwarth, Odette, et al.
Publicado: (2018)

Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study
por: Shebl, F M, et al.
Publicado: (2012)

Incidence and distribution of advanced colorectal adenomas in patients undergoing colonoscopy for screening, surveillance, and symptoms
por: Kang, Haifeng, et al.
Publicado: (2018)

Serum α-Tocopherol and γ-Tocopherol Concentrations and Prostate Cancer Risk in the PLCO Screening Trial: A Nested Case-Control Study
por: Weinstein, Stephanie J., et al.
Publicado: (2012)

Gut Microbiome–Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort
por: Reichard, Chad A., et al.
Publicado: (2022)

OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations
por: Pan, Zoucheng, et al.
Publicado: (2023)

Integrative Genomic Analysis Reveals Extended Germline Homozygosity with Lung Cancer Risk in the PLCO Cohort
por: Orloff, Mohammed S., et al.
Publicado: (2012)

Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials
por: Gelfond, Jonathan A., et al.
Publicado: (2022)

Chocolate consumption and all-cause and cause-specific mortality in a US population: a post hoc analysis of the PLCO cancer screening trial
por: Zhong, Guo-Chao, et al.
Publicado: (2021)

Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan
por: Chien, Li-Hsin, et al.
Publicado: (2022)

Higher Adenoma Detection Rates at Screening Associated With Lower Long-Term Colorectal Cancer Incidence and Mortality
por: Cross, Amanda J., et al.
Publicado: (2022)

Analysis of lung cancer risk model (PLCO(M2012) and LLP(v2)) performance in a community-based lung cancer screening programme
por: Lebrett, Mikey B, et al.
Publicado: (2020)

Lower Incidence of K‐ras Codon 12 Mutation in Flat Colorectal Adenomas than in Polypoid Adenomas
por: Yamagata, Seiichi, et al.
Publicado: (1994)

Adenoma detection rates in an opportunistic screening colonoscopy program in Iran, a country with rising colorectal cancer incidence
por: Delavari, Alireza, et al.
Publicado: (2014)

OR27-4 The Impact of Overweight and Obesity on US Trends in Papillary Thyroid Cancer Incidence
por: Kitahara, Cari, et al.
Publicado: (2019)

Correlation between Metabolite of Prostaglandin E2 and the incidence of colorectal adenomas
por: Jiang, Jia, et al.
Publicado: (2023)

Colorectal Adenomas—Genetics and Searching for New Molecular Screening Biomarkers
por: Siskova, Anna, et al.
Publicado: (2020)

Association of Family History With Cancer Recurrence, Survival, and the Incidence of Colorectal Adenoma in Patients With Colorectal Cancer
por: Park, Yehyun, et al.
Publicado: (2019)

Paneth Cell in Adenomas of the Distal Colorectum Is Inversely Associated with Synchronous Advanced Adenoma and Carcinoma
por: Mahon, Megan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r8573636kq4qiste4lhnak68qs